Skip to main content
. 2014 Jun 4;34(23):7845–7861. doi: 10.1523/JNEUROSCI.2960-13.2014

Table 1.

Titer and timing of viral injections

Cre driver Cell type Titer of rAAVa (genome copies) rAAV injection site Titer of RVa (infectious units) RV injection site Timing of RV injection (post rAAV injection)
CRH CRH-1 AC 5 × 109 Eye 500–1000 Eye 5 weeks
CRH CRH-2 AC
VIP VIP-1 AC
nNOS nNOS-1 AC
nNOS nNOS-2 AC
SST SST-1 AC
CCK SAC
CCK A17
CCK CCK-1 RGC 1 × 1010 Eye 106 LGN or SC 5 weeks
CCK CCK-2 RGC
CCK CCK-3 RGC
CCK M1 cells 1.5 × 109 M1 300 M1 3 weeks
CCK S1 cells S1 S1
CCK V1 cells V1 V1
CCK SC cells SC SC
SST M1 cells 1.5 × 109 M1 30 M1 3 weeks
SST S1 cells S1 S1
SST V1 cells V1 V1
SST SC cells SC SC
CCK LGN cells 1.5 × 109 LGN 3000 LGN 3 weeks
SST LGN cells 1.5 × 109 LGN 3000 LGN 3 weeks

AC, Amacrine cell.

arAAV2 (YF4)-CBA-DIO- TVA.

bRabies virus EnvA-SADΔG-GFP.